HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suzanne F Jones Selected Research

Suzanne F Jones Research Topics

Disease

42Neoplasms (Cancer)
11/2022 - 01/2002
9Thrombocytopenia (Thrombopenia)
12/2015 - 05/2003
8Nausea
03/2016 - 11/2005
8Neutropenia
12/2015 - 05/2003
8Diarrhea
08/2013 - 05/2003
7Breast Neoplasms (Breast Cancer)
11/2021 - 01/2002
6Fatigue
03/2016 - 06/2008
6Exanthema (Rash)
08/2013 - 08/2005
5Vomiting
03/2016 - 11/2005
5Disease Progression
01/2014 - 05/2003
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2019 - 05/2003
4Febrile Neutropenia
06/2013 - 11/2009
2Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 03/2016
2Anorexia
03/2016 - 04/2009
2Mucositis
02/2015 - 01/2010
2Colorectal Neoplasms (Colorectal Cancer)
02/2015 - 04/2013
2Anemia
01/2014 - 06/2010
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
06/2010 - 11/2009
2Lung Neoplasms (Lung Cancer)
05/2005 - 05/2003
1Microsatellite Instability
11/2021
1Carcinogenesis
05/2020
1Leiomyosarcoma
03/2016
1Pain (Aches)
12/2015
1Thrombocytopenia 1
02/2015
1Hemorrhage
02/2015
1Body Weight (Weight, Body)
01/2015
1Edema (Dropsy)
01/2014
1Uveitis
06/2013
1Proteinuria
11/2011

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
05/2020 - 08/2005
7Carboplatin (JM8)FDA LinkGeneric
12/2019 - 05/2003
5Irinotecan (Camptosar)FDA LinkGeneric
01/2015 - 05/2003
4Paclitaxel (Taxol)FDA LinkGeneric
09/2012 - 01/2002
4Lapatinib (GW572016)FDA Link
11/2009 - 08/2005
3Pemetrexed (MTA)FDA Link
12/2019 - 01/2010
3pazopanibFDA Link
08/2013 - 01/2010
3Transaminases (Aminotransferases)IBA
06/2013 - 01/2010
3GemcitabineFDA Link
07/2012 - 01/2011
3Trastuzumab (Herceptin)FDA Link
04/2009 - 08/2005
2Biomarkers (Surrogate Marker)IBA
11/2022 - 11/2021
2Immune Checkpoint InhibitorsIBA
11/2022 - 11/2021
2Proteins (Proteins, Gene)FDA Link
12/2015 - 06/2011
2EnzymesIBA
12/2015 - 08/2013
2romidepsin (FK228)FDA Link
12/2015 - 07/2012
2Capecitabine (Xeloda)FDA Link
01/2015 - 05/2010
2Tyrosine Kinase InhibitorsIBA
08/2013 - 04/2009
2PanobinostatIBA
09/2012 - 03/2011
2Topotecan (Hycamtin)FDA LinkGeneric
06/2010 - 01/2010
2ErbB Receptors (EGF Receptor)IBA
04/2009 - 08/2005
2Docetaxel (Taxotere)FDA Link
06/2008 - 05/2005
2Gefitinib (Iressa)FDA Link
09/2005 - 05/2003
1cyclopropapyrroloindoleIBA
11/2022
1adavosertibIBA
01/2022
1PlatinumIBA
01/2022
1HSP27 Heat-Shock ProteinsIBA
12/2019
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2019
1apatorsenIBA
12/2019
1Antisense OligonucleotidesIBA
12/2019
1Messenger RNA (mRNA)IBA
12/2019
1LY900009IBA
03/2016
1LipidsIBA
12/2015
1Cytochrome P-450 CYP3A InhibitorsIBA
12/2015
1Rifampin (Rifampicin)FDA LinkGeneric
12/2015
1Ketoconazole (Nizoral)FDA LinkGeneric
12/2015
1Cytochrome P-450 CYP3AIBA
12/2015
1Ranitidine (Zantac)FDA LinkGeneric
12/2015
1Focal Adhesion Protein-Tyrosine KinasesIBA
10/2015
1defactinibIBA
10/2015
1dactolisibIBA
04/2015
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
04/2015
1ME-344IBA
04/2015
1EverolimusFDA Link
02/2015
13- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA
02/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2015
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
01/2015
1Biological ProductsIBA
07/2014
1ME-143IBA
02/2014
1NADH oxidaseIBA
02/2014
1human ALK1-Fc fusion proteinIBA
01/2014
1DiureticsIBA
01/2014
1LigandsIBA
01/2014
1Activin Receptors (Activin Receptor)IBA
01/2014
1carfilzomibIBA
10/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
10/2013
1Proteasome InhibitorsIBA
10/2013
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2013
1Epidermal Growth Factor (EGF)IBA
08/2013
1Monoclonal AntibodiesIBA
04/2013
1Glycoproteins (Glycoprotein)IBA
04/2013
1KRN-330IBA
04/2013
1Angiogenesis InhibitorsIBA
08/2012
1vatalanib (PTK787)IBA
11/2011
1Bevacizumab (Avastin)FDA Link
11/2011

Therapy/Procedure

10Therapeutics
03/2016 - 05/2003
4Drug Therapy (Chemotherapy)
01/2022 - 01/2011
1Precision Medicine
11/2022
1Time-to-Treatment
11/2021
1Premedication
01/2016
1Drug Tapering
08/2013
1Oral Administration
09/2012